These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26044366)

  • 21. Protein interaction disruption in cancer.
    Ruffalo M; Bar-Joseph Z
    BMC Cancer; 2019 Apr; 19(1):370. PubMed ID: 31014259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of hub subnetwork based on topological features of genes in breast cancer.
    Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
    Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Edge biomarkers for classification and prediction of phenotypes.
    Zeng T; Zhang W; Yu X; Liu X; Li M; Liu R; Chen L
    Sci China Life Sci; 2014 Nov; 57(11):1103-14. PubMed ID: 25326072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small molecule tyrosine kinase inhibitors of ErbB2/HER2/Neu in the treatment of aggressive breast cancer.
    Schroeder RL; Stevens CL; Sridhar J
    Molecules; 2014 Sep; 19(9):15196-212. PubMed ID: 25251190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice.
    Gil EY; Jo UH; Lee HJ; Kang J; Seo JH; Lee ES; Kim YH; Kim I; Phan-Lai V; Disis ML; Park KH
    Breast Cancer Res Treat; 2014 Aug; 147(1):69-80. PubMed ID: 25104444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MCentridFS: a tool for identifying module biomarkers for multi-phenotypes from high-throughput data.
    Wen Z; Zhang W; Zeng T; Chen L
    Mol Biosyst; 2014 Nov; 10(11):2870-5. PubMed ID: 25099602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of significant pathways in breast cancer metastasis via module extraction and comparison.
    Wang X; Qian H; Zhang S
    IET Syst Biol; 2014 Apr; 8(2):47-55. PubMed ID: 25014225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EdgeMarker: Identifying differentially correlated molecule pairs as edge-biomarkers.
    Zhang W; Zeng T; Chen L
    J Theor Biol; 2014 Dec; 362():35-43. PubMed ID: 24931676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer.
    Al-Ejeh F; Miranda M; Shi W; Simpson PT; Song S; Vargas AC; Saunus JM; Smart CE; Mariasegaram M; Wiegmans AP; Chenevix-Trench G; Lakhani SR; Khanna KK
    Oncotarget; 2014 May; 5(10):3145-58. PubMed ID: 24762669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deciphering early development of complex diseases by progressive module network.
    Zeng T; Zhang CC; Zhang W; Liu R; Liu J; Chen L
    Methods; 2014 Jun; 67(3):334-43. PubMed ID: 24561825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying critical transitions of complex diseases based on a single sample.
    Liu R; Yu X; Liu X; Xu D; Aihara K; Chen L
    Bioinformatics; 2014 Jun; 30(11):1579-86. PubMed ID: 24519381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma.
    Zawadzka AM; Schilling B; Cusack MP; Sahu AK; Drake P; Fisher SJ; Benz CC; Gibson BW
    Mol Cell Proteomics; 2014 Apr; 13(4):1034-49. PubMed ID: 24505115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatio-temporal analysis of type 2 diabetes mellitus based on differential expression networks.
    Sun SY; Liu ZP; Zeng T; Wang Y; Chen L
    Sci Rep; 2013; 3():2268. PubMed ID: 23881262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells.
    Yu SL; Lee DC; Son JW; Park CG; Lee HY; Kang J
    Oncol Rep; 2013 Sep; 30(3):1293-300. PubMed ID: 23817620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers.
    Liu R; Wang X; Aihara K; Chen L
    Med Res Rev; 2014 May; 34(3):455-78. PubMed ID: 23775602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ellipsoidFN: a tool for identifying a heterogeneous set of cancer biomarkers based on gene expressions.
    Ren X; Wang Y; Chen L; Zhang XS; Jin Q
    Nucleic Acids Res; 2013 Feb; 41(4):e53. PubMed ID: 23262226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasion.
    Mouneimne G; Hansen SD; Selfors LM; Petrak L; Hickey MM; Gallegos LL; Simpson KJ; Lim J; Gertler FB; Hartwig JH; Mullins RD; Brugge JS
    Cancer Cell; 2012 Nov; 22(5):615-30. PubMed ID: 23153535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revealing metabolite biomarkers for acupuncture treatment by linear programming based feature selection.
    Wang Y; Wu QF; Chen C; Wu LY; Yan XZ; Yu SG; Zhang XS; Liang FR
    BMC Syst Biol; 2012; 6 Suppl 1(Suppl 1):S15. PubMed ID: 23046877
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.